The Claim

In healthy middle-aged adults, the administration of nitroglycerin during insulin stimulation reduces myocardial glucose uptake without altering myocardial blood flow, indicating that nitric oxide donors may directly or indirectly suppress cardiac glucose transport independently of changes in perfusion.

Source: Insulin-Stimulated Myocardial Glucose Uptake and the Relation to Perfusion and the Nitric Oxide System

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
40score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

Taking nitroglycerin while insulin is active might lower how much sugar the heart uses, even if blood flow to the heart stays the same.

See the scientific wording

Nitroglycerin administration during insulin stimulation reduces myocardial glucose uptake without changing myocardial blood flow in healthy middle-aged adults, suggesting that nitric oxide donors may directly or indirectly suppress glucose transport in the heart independent of perfusion.

What the research says

1 study

  1. Study: Insulin-Stimulated Myocardial Glucose Uptake and the Relation to Perfusion and the Nitric Oxide System

    The study found that giving nitroglycerin while stimulating insulin lowers heart glucose use without changing blood flow, which supports the idea that nitroglycerin affects how the heart takes in sugar regardless of blood supply.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.